Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
BACKGROUND: Although the eradication of Helicobacter pylori is of primary importance when initiating treatment, it is also important to have a strategy for patients who are H pylori-negative, fail to demonstrate eradication or have a tendency to become re-infected or relapse.
Saved in:
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1999-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1999/395876 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832553522764185600 |
---|---|
author | K Lauritsen K Rutgersson E Bolling G Brunner S Eriksson JP Galmiche A Walan AP Archambault H Gudjónsson RJ Bailey G Bianchi Porro L Frison N Havu ABR Thompson |
author_facet | K Lauritsen K Rutgersson E Bolling G Brunner S Eriksson JP Galmiche A Walan AP Archambault H Gudjónsson RJ Bailey G Bianchi Porro L Frison N Havu ABR Thompson |
author_sort | K Lauritsen |
collection | DOAJ |
description | BACKGROUND: Although the eradication of Helicobacter pylori is of primary importance when initiating treatment, it is also important to have a strategy for patients who are H pylori-negative, fail to demonstrate eradication or have a tendency to become re-infected or relapse. |
format | Article |
id | doaj-art-165a5db58c974870966171236b77b51b |
institution | Kabale University |
issn | 0835-7900 |
language | English |
publishDate | 1999-01-01 |
publisher | Wiley |
record_format | Article |
series | Canadian Journal of Gastroenterology |
spelling | doaj-art-165a5db58c974870966171236b77b51b2025-02-03T05:53:45ZengWileyCanadian Journal of Gastroenterology0835-79001999-01-01131080681310.1155/1999/395876Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer DiseaseK Lauritsen0K Rutgersson1E Bolling2G Brunner3S Eriksson4JP Galmiche5A Walan6AP Archambault7H Gudjónsson8RJ Bailey9G Bianchi Porro10L Frison11N Havu12ABR Thompson13Odense University Hospital, DenmarkAstra Hässle AB, Mölndal, SwedenAstra Hässle AB, Mölndal, SwedenMedizinische Hochschule Hannover, GermanyMedizinische Hochschule Hannover, GermanyHôpital Guillaume et René Laënnec, Nantes, FranceAstra Hässle AB, Mölndal, SwedenUniversity Hospital, Montreal, CanadaLandspítalinn, Reykjavík, IcelandRoyal Alexandra Hospital, Edmonton, Alberta, CanadaOspedale “L Sacco”, Milano, ItalyAstra Hässle AB, Mölndal, SwedenAB Astra, Södertälje, SwedenUniversity of Alberta, Edmonton, Alberta, CanadaBACKGROUND: Although the eradication of Helicobacter pylori is of primary importance when initiating treatment, it is also important to have a strategy for patients who are H pylori-negative, fail to demonstrate eradication or have a tendency to become re-infected or relapse.http://dx.doi.org/10.1155/1999/395876 |
spellingShingle | K Lauritsen K Rutgersson E Bolling G Brunner S Eriksson JP Galmiche A Walan AP Archambault H Gudjónsson RJ Bailey G Bianchi Porro L Frison N Havu ABR Thompson Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease Canadian Journal of Gastroenterology |
title | Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease |
title_full | Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease |
title_fullStr | Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease |
title_full_unstemmed | Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease |
title_short | Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease |
title_sort | omeprazole and ranitidine in the prevention of relapse in patients with duodenal ulcer disease |
url | http://dx.doi.org/10.1155/1999/395876 |
work_keys_str_mv | AT klauritsen omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT krutgersson omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT ebolling omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT gbrunner omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT seriksson omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT jpgalmiche omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT awalan omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT aparchambault omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT hgudjonsson omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT rjbailey omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT gbianchiporro omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT lfrison omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT nhavu omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease AT abrthompson omeprazoleandranitidineinthepreventionofrelapseinpatientswithduodenalulcerdisease |